Aceragen | Fremdkapital



Loan Capital Veränderung Datum
Abbott USD 12.74B 111M 2025-03
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amgen USD 54.01B 2.54B 2025-03
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.65M 244K 2025-03
Cipla INR 2.52B 345.6M 2025-03
Clal Biotechnology ILS 25.96M 18.48M 2023-12
Compugen USD 0 0 2024-12
CSL USD 9.33B 1.91B 2024-12
Dynavax Technologies USD 260.51M 36.65M 2025-03
Eli Lilly USD 34.5B 5.97B 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
Grifols EUR 8.68B 155.99M 2024-12
Merck USD 33.48B 978M 2025-03
Pfizer USD 57.64B 234M 2025-03
Roche Holding CHF 32.1B 1.94B 2024-12
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
Ultragenyx Pharmaceutical USD 0 0 2024-12
X T L Biopharmaceuticals 0 0 2024-12



Aceragen Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.